Angion Biomedica Corp ANGN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 9:30 AM EDT
0.9101quote price arrow down-0.0115 (-1.2478%)
Volume
244
52 week range
0.91 - 10.57
Loading...
  • Open0.9101
  • Day High0.9101
  • Day Low0.9101
  • Prev Close0.9216
  • 52 Week High10.57
  • 52 Week High Date09/28/21
  • 52 Week Low0.91
  • 52 Week Low Date09/27/22

Key Stats

  • Market Cap27.40M
  • Shares Out30.11M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-68.22

KEY STATS

  • Open0.9101
  • Day High0.9101
  • Day Low0.9101
  • Prev Close0.9216
  • 52 Week High10.57
  • 52 Week High Date09/28/21
  • 52 Week Low0.91
  • 52 Week Low Date09/27/22
  • Market Cap27.40M
  • Shares Out30.11M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-68.22

RATIOS/PROFITABILITY

  • EPS (TTM)-0.81
  • P/E (TTM)-1.12
  • Fwd P/E (NTM)-0.48
  • EBITDA (TTM)-24.51M
  • ROE (TTM)-35.33%
  • Revenue (TTM)29.70M
  • Gross Margin (TTM)90.80%
  • Net Margin (TTM)-81.45%
  • Debt To Equity (MRQ)0.44%

EVENTS

  • Earnings Date11/10/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Angion Biomedica Corp

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Angion Biomedica Corp. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address chronic and progressive fibrotic diseases. The Company’s products include ANG-3070, ROCK2 Inhibitor, CYP11B2 Inhibitor and ANG-3777. ANG-3070 is a highly selective oral tyrosine kinase receptor inhibitor (TKI) in development as a treatment for fibrotic diseases, particularly in the kidney and lung....
Jay Venkatesan M.D.
Chairman of the Board, President, Chief Executive Officer
Itzhak Goldberg M.D.
Chairman Emeritus, Director
Gregory Curhan
Chief Financial Officer
Jennifer Rhodes J.D.
Executive Vice President, Chief Business Officer, Chief Compliance Officer, General Counsel, Corporate Secretary
Address
51 Charles Lindbergh Boulevard
Uniondale, NY
11553
United States

Top Peers

SYMBOLLASTCHG%CHG
ORGS
Orgenesis Inc
1.41+0.01+0.71%
SYRS
Syros Pharmaceuticals Inc
5.43+0.09+1.68%
MTEM
Molecular Templates Inc
0.6578+0.0048+0.74%
HARP
Harpoon Therapeutics Inc
0.9595+0.0395+4.29%
CDTX
Cidara Therapeutics Inc
0.65+0.021+3.34%